CERC
Price:
$2.93
Market Cap:
$38.63M
Cerecor Inc. operates as a biopharmaceutical firm dedicated to the discovery and marketing of therapeutic solutions, primarily addressing rare pediatric and orphan diseases. The company maintains an active pipeline, including: Inherited Metabolic Disorders: Advancing CERC-801 and CERC-802, both of which have successfully completed Phase I clinical trials, alongside CERC-803. Autoimmune Inflammatory Conditions: Developing CERC-007, an anti-IL-18 monoclonal antibody, designed to combat ailments such as adult-onset Still's disease and multiple myeloma. Complex Lymphatic Malformations: Progressing CERC-006, a dual mTOR inhibitor. Pediatric-onset Crohn's Disease: Working on CERC-002, an anti-LIGH...[Read more]
Industry
Biotechnology
IPO Date
2015-11-13
Stock Exchange
NASDAQ
Ticker
CERC
According to Cerecor Inc.’s latest financial reports and current stock price. The company's current ROE is -112.68%. This represents a change of 294.01% compared to the average of -28.60% of the last 4 quarters.
The mean historical ROE of Cerecor Inc. over the last ten years is -60.32%. The current -112.68% ROE has changed 86.81% with respect to the historical average. Over the past ten years (40 quarters), CERC's ROE was at its highest in in the December 2024 quarter at 0%. The ROE was at its lowest in in the September 2025 quarter at -33.45%.
Average
-60.32%
Median
-60.32%
Minimum
-94.23%
Maximum
-26.41%
Discovering the peaks and valleys of Cerecor Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 256.85%
Maximum Annual ROE = -26.41%
Minimum Annual Increase = 0%
Minimum Annual ROE = -94.23%
| Year | ROE | Change |
|---|---|---|
| 2025 | -94.23% | 256.85% |
The current ROE of Cerecor Inc. (CERC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-60.32%
5-year avg
-60.32%
10-year avg
-60.32%
Cerecor Inc.’s ROE is greater than Lumos Pharma, Inc. (-78.34%), less than Pluristem Therapeutics Inc. (79.27%), less than Satsuma Pharmaceuticals, Inc. (125.24%), greater than Oruka Therapeutics, Inc. (-25.99%), greater than Grace Therapeutics, Inc. (-12.66%), greater than Magenta Therapeutics, Inc. (-27.30%), less than LianBio (11.78%), less than Opus Genetics, Inc. (6.07%), less than Lunai Bioworks Inc. (892.52%), greater than Qilian International Holding Group Limited (-16.24%),
| Company | ROE | Market cap |
|---|---|---|
| -78.34% | $37.54M | |
| 79.27% | $40.85M | |
| 125.24% | $36.47M | |
| -25.99% | $2.62B | |
| -12.66% | $34.04M | |
| -27.30% | $42.44M | |
| 11.78% | $17.46M | |
| 6.07% | $328.84M | |
| 892.52% | $32.92M | |
| -16.24% | $38.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cerecor Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cerecor Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cerecor Inc.'s ROE?
How is the ROE calculated for Cerecor Inc. (CERC)?
What is the highest ROE for Cerecor Inc. (CERC)?
What is the 3-year average ROE for Cerecor Inc. (CERC)?
What is the 5-year average ROE for Cerecor Inc. (CERC)?
How does the current ROE for Cerecor Inc. (CERC) compare to its historical average?